nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—CYP2C9—Vismodegib—skin cancer	0.291	0.738	CbGbCtD
Cyclizine—CYP2C9—Fluorouracil—skin cancer	0.103	0.262	CbGbCtD
Cyclizine—HRH1—nose—skin cancer	0.0404	0.227	CbGeAlD
Cyclizine—SULT1E1—nipple—skin cancer	0.0367	0.207	CbGeAlD
Cyclizine—SULT1E1—mammalian vulva—skin cancer	0.0215	0.121	CbGeAlD
Cyclizine—SULT1E1—lymphoid tissue—skin cancer	0.019	0.107	CbGeAlD
Cyclizine—SULT1E1—female reproductive system—skin cancer	0.0184	0.104	CbGeAlD
Cyclizine—Altered state of consciousness—Temozolomide—skin cancer	0.0122	0.0285	CcSEcCtD
Cyclizine—SULT1E1—lymph node—skin cancer	0.0107	0.0606	CbGeAlD
Cyclizine—Connective tissue disorder—Vismodegib—skin cancer	0.0088	0.0206	CcSEcCtD
Cyclizine—Hepatic function abnormal—Imiquimod—skin cancer	0.0078	0.0182	CcSEcCtD
Cyclizine—Muscle spasms—Vismodegib—skin cancer	0.00749	0.0175	CcSEcCtD
Cyclizine—Blister—Fluorouracil—skin cancer	0.0072	0.0168	CcSEcCtD
Cyclizine—HRH1—nipple—skin cancer	0.00657	0.037	CbGeAlD
Cyclizine—Speech disorder—Temozolomide—skin cancer	0.00654	0.0153	CcSEcCtD
Cyclizine—Urinary retention—Imiquimod—skin cancer	0.00648	0.0151	CcSEcCtD
Cyclizine—Nervous system disorder—Vismodegib—skin cancer	0.00624	0.0146	CcSEcCtD
Cyclizine—Skin disorder—Vismodegib—skin cancer	0.00618	0.0144	CcSEcCtD
Cyclizine—Speech disorder—Fluorouracil—skin cancer	0.00603	0.0141	CcSEcCtD
Cyclizine—Constipation—Vismodegib—skin cancer	0.00544	0.0127	CcSEcCtD
Cyclizine—Pain—Vismodegib—skin cancer	0.00544	0.0127	CcSEcCtD
Cyclizine—Depressed level of consciousness—Temozolomide—skin cancer	0.00544	0.0127	CcSEcCtD
Cyclizine—Connective tissue disorder—Vemurafenib—skin cancer	0.00544	0.0127	CcSEcCtD
Cyclizine—Disorientation—Bleomycin—skin cancer	0.00542	0.0127	CcSEcCtD
Cyclizine—Eye disorder—Vemurafenib—skin cancer	0.00517	0.0121	CcSEcCtD
Cyclizine—Hepatobiliary disease—Imiquimod—skin cancer	0.00497	0.0116	CcSEcCtD
Cyclizine—Chills—Vemurafenib—skin cancer	0.00496	0.0116	CcSEcCtD
Cyclizine—Erythema—Vemurafenib—skin cancer	0.00482	0.0112	CcSEcCtD
Cyclizine—Thrombophlebitis—Temozolomide—skin cancer	0.00472	0.011	CcSEcCtD
Cyclizine—HRH1—connective tissue—skin cancer	0.00466	0.0262	CbGeAlD
Cyclizine—Connective tissue disorder—Imiquimod—skin cancer	0.00464	0.0108	CcSEcCtD
Cyclizine—Asthenia—Vismodegib—skin cancer	0.00456	0.0107	CcSEcCtD
Cyclizine—Pruritus—Vismodegib—skin cancer	0.0045	0.0105	CcSEcCtD
Cyclizine—HRH1—epithelium—skin cancer	0.00442	0.0249	CbGeAlD
Cyclizine—Eye disorder—Imiquimod—skin cancer	0.00441	0.0103	CcSEcCtD
Cyclizine—Thrombophlebitis—Fluorouracil—skin cancer	0.00435	0.0102	CcSEcCtD
Cyclizine—Chills—Imiquimod—skin cancer	0.00423	0.00989	CcSEcCtD
Cyclizine—Disorientation—Fluorouracil—skin cancer	0.00421	0.00983	CcSEcCtD
Cyclizine—Mental disorder—Imiquimod—skin cancer	0.00413	0.00966	CcSEcCtD
Cyclizine—Bronchospasm—Bleomycin—skin cancer	0.00412	0.00962	CcSEcCtD
Cyclizine—Erythema—Imiquimod—skin cancer	0.00411	0.00959	CcSEcCtD
Cyclizine—Dermatitis bullous—Fluorouracil—skin cancer	0.00394	0.0092	CcSEcCtD
Cyclizine—Anaphylactic shock—Vemurafenib—skin cancer	0.00393	0.00918	CcSEcCtD
Cyclizine—Nervous system disorder—Vemurafenib—skin cancer	0.00385	0.009	CcSEcCtD
Cyclizine—HRH1—mammalian vulva—skin cancer	0.00384	0.0216	CbGeAlD
Cyclizine—Skin disorder—Vemurafenib—skin cancer	0.00382	0.00892	CcSEcCtD
Cyclizine—Agitation—Imiquimod—skin cancer	0.00377	0.00882	CcSEcCtD
Cyclizine—Angioedema—Imiquimod—skin cancer	0.00375	0.00877	CcSEcCtD
Cyclizine—Injection site reaction—Docetaxel—skin cancer	0.00372	0.00869	CcSEcCtD
Cyclizine—Hypotension—Vemurafenib—skin cancer	0.00367	0.00858	CcSEcCtD
Cyclizine—Convulsion—Imiquimod—skin cancer	0.00356	0.00831	CcSEcCtD
Cyclizine—Hypertension—Imiquimod—skin cancer	0.00355	0.00828	CcSEcCtD
Cyclizine—Constipation—Vemurafenib—skin cancer	0.00336	0.00785	CcSEcCtD
Cyclizine—CYP2C9—female reproductive system—skin cancer	0.00333	0.0188	CbGeAlD
Cyclizine—Nervous system disorder—Imiquimod—skin cancer	0.00329	0.00768	CcSEcCtD
Cyclizine—HRH1—female reproductive system—skin cancer	0.00328	0.0185	CbGeAlD
Cyclizine—Tachycardia—Imiquimod—skin cancer	0.00327	0.00764	CcSEcCtD
Cyclizine—Skin disorder—Imiquimod—skin cancer	0.00326	0.00761	CcSEcCtD
Cyclizine—Agranulocytosis—Dactinomycin—skin cancer	0.00325	0.00759	CcSEcCtD
Cyclizine—Thrombophlebitis—Docetaxel—skin cancer	0.00314	0.00733	CcSEcCtD
Cyclizine—Hepatitis—Dactinomycin—skin cancer	0.00313	0.0073	CcSEcCtD
Cyclizine—Insomnia—Imiquimod—skin cancer	0.00303	0.00708	CcSEcCtD
Cyclizine—Paraesthesia—Imiquimod—skin cancer	0.00301	0.00703	CcSEcCtD
Cyclizine—Chills—Bleomycin—skin cancer	0.00301	0.00703	CcSEcCtD
Cyclizine—Somnolence—Imiquimod—skin cancer	0.00298	0.00696	CcSEcCtD
Cyclizine—Hepatobiliary disease—Temozolomide—skin cancer	0.00298	0.00696	CcSEcCtD
Cyclizine—Erythema—Bleomycin—skin cancer	0.00292	0.00682	CcSEcCtD
Cyclizine—Hypersensitivity—Vemurafenib—skin cancer	0.0029	0.00676	CcSEcCtD
Cyclizine—Pain—Imiquimod—skin cancer	0.00287	0.0067	CcSEcCtD
Cyclizine—Dermatitis bullous—Docetaxel—skin cancer	0.00284	0.00664	CcSEcCtD
Cyclizine—Hepatitis—Temozolomide—skin cancer	0.00283	0.0066	CcSEcCtD
Cyclizine—Asthenia—Vemurafenib—skin cancer	0.00282	0.00659	CcSEcCtD
Cyclizine—Chills—Dactinomycin—skin cancer	0.0028	0.00655	CcSEcCtD
Cyclizine—Pruritus—Vemurafenib—skin cancer	0.00278	0.0065	CcSEcCtD
Cyclizine—Connective tissue disorder—Temozolomide—skin cancer	0.00278	0.00649	CcSEcCtD
Cyclizine—HRH1—head—skin cancer	0.00274	0.0155	CbGeAlD
Cyclizine—Erythema—Dactinomycin—skin cancer	0.00272	0.00636	CcSEcCtD
Cyclizine—Agranulocytosis—Fluorouracil—skin cancer	0.00271	0.00633	CcSEcCtD
Cyclizine—Urticaria—Imiquimod—skin cancer	0.00266	0.00622	CcSEcCtD
Cyclizine—Eye disorder—Temozolomide—skin cancer	0.00264	0.00617	CcSEcCtD
Cyclizine—Dizziness—Vemurafenib—skin cancer	0.0026	0.00607	CcSEcCtD
Cyclizine—Chills—Temozolomide—skin cancer	0.00254	0.00593	CcSEcCtD
Cyclizine—Mental disorder—Temozolomide—skin cancer	0.00248	0.00579	CcSEcCtD
Cyclizine—Hypersensitivity—Imiquimod—skin cancer	0.00247	0.00577	CcSEcCtD
Cyclizine—Headache—Vemurafenib—skin cancer	0.00246	0.00575	CcSEcCtD
Cyclizine—Erythema—Temozolomide—skin cancer	0.00246	0.00575	CcSEcCtD
Cyclizine—Asthenia—Imiquimod—skin cancer	0.0024	0.00562	CcSEcCtD
Cyclizine—Anaphylactic shock—Bleomycin—skin cancer	0.00238	0.00556	CcSEcCtD
Cyclizine—Pruritus—Imiquimod—skin cancer	0.00237	0.00554	CcSEcCtD
Cyclizine—Vision blurred—Temozolomide—skin cancer	0.00232	0.00542	CcSEcCtD
Cyclizine—Bronchospasm—Docetaxel—skin cancer	0.00231	0.0054	CcSEcCtD
Cyclizine—Tremor—Temozolomide—skin cancer	0.00231	0.00539	CcSEcCtD
Cyclizine—Erythema—Fluorouracil—skin cancer	0.00227	0.0053	CcSEcCtD
Cyclizine—Agitation—Temozolomide—skin cancer	0.00226	0.00528	CcSEcCtD
Cyclizine—Angioedema—Temozolomide—skin cancer	0.00225	0.00525	CcSEcCtD
Cyclizine—Hypotension—Bleomycin—skin cancer	0.00222	0.0052	CcSEcCtD
Cyclizine—Dizziness—Imiquimod—skin cancer	0.00222	0.00518	CcSEcCtD
Cyclizine—Paraesthesia—Bleomycin—skin cancer	0.00214	0.00499	CcSEcCtD
Cyclizine—Vision blurred—Fluorouracil—skin cancer	0.00214	0.00499	CcSEcCtD
Cyclizine—Convulsion—Temozolomide—skin cancer	0.00213	0.00498	CcSEcCtD
Cyclizine—Hypertension—Temozolomide—skin cancer	0.00212	0.00496	CcSEcCtD
Cyclizine—Headache—Imiquimod—skin cancer	0.0021	0.00491	CcSEcCtD
Cyclizine—Pain—Bleomycin—skin cancer	0.00204	0.00476	CcSEcCtD
Cyclizine—Anaphylactic shock—Temozolomide—skin cancer	0.00201	0.00469	CcSEcCtD
Cyclizine—Hepatobiliary disease—Docetaxel—skin cancer	0.00198	0.00463	CcSEcCtD
Cyclizine—Nervous system disorder—Temozolomide—skin cancer	0.00197	0.0046	CcSEcCtD
Cyclizine—Convulsion—Fluorouracil—skin cancer	0.00196	0.00459	CcSEcCtD
Cyclizine—Agranulocytosis—Docetaxel—skin cancer	0.00195	0.00457	CcSEcCtD
Cyclizine—Skin disorder—Temozolomide—skin cancer	0.00195	0.00456	CcSEcCtD
Cyclizine—HRH1—lymph node—skin cancer	0.00192	0.0108	CbGeAlD
Cyclizine—Pain—Dactinomycin—skin cancer	0.0019	0.00444	CcSEcCtD
Cyclizine—Urticaria—Bleomycin—skin cancer	0.00189	0.00442	CcSEcCtD
Cyclizine—Hepatitis—Docetaxel—skin cancer	0.00188	0.00439	CcSEcCtD
Cyclizine—Anaphylactic shock—Fluorouracil—skin cancer	0.00185	0.00432	CcSEcCtD
Cyclizine—Connective tissue disorder—Docetaxel—skin cancer	0.00185	0.00432	CcSEcCtD
Cyclizine—Insomnia—Temozolomide—skin cancer	0.00182	0.00424	CcSEcCtD
Cyclizine—Nervous system disorder—Fluorouracil—skin cancer	0.00181	0.00424	CcSEcCtD
Cyclizine—Tachycardia—Fluorouracil—skin cancer	0.00181	0.00422	CcSEcCtD
Cyclizine—Paraesthesia—Temozolomide—skin cancer	0.0018	0.00421	CcSEcCtD
Cyclizine—Somnolence—Temozolomide—skin cancer	0.00179	0.00417	CcSEcCtD
Cyclizine—Eye disorder—Docetaxel—skin cancer	0.00176	0.0041	CcSEcCtD
Cyclizine—Hypersensitivity—Bleomycin—skin cancer	0.00175	0.0041	CcSEcCtD
Cyclizine—Hypotension—Fluorouracil—skin cancer	0.00173	0.00404	CcSEcCtD
Cyclizine—Constipation—Temozolomide—skin cancer	0.00172	0.00401	CcSEcCtD
Cyclizine—Pain—Temozolomide—skin cancer	0.00172	0.00401	CcSEcCtD
Cyclizine—Asthenia—Bleomycin—skin cancer	0.00171	0.00399	CcSEcCtD
Cyclizine—Chills—Docetaxel—skin cancer	0.00169	0.00394	CcSEcCtD
Cyclizine—Pruritus—Bleomycin—skin cancer	0.00168	0.00394	CcSEcCtD
Cyclizine—Insomnia—Fluorouracil—skin cancer	0.00167	0.00391	CcSEcCtD
Cyclizine—Paraesthesia—Fluorouracil—skin cancer	0.00166	0.00388	CcSEcCtD
Cyclizine—Mental disorder—Docetaxel—skin cancer	0.00165	0.00385	CcSEcCtD
Cyclizine—Somnolence—Fluorouracil—skin cancer	0.00165	0.00384	CcSEcCtD
Cyclizine—Erythema—Docetaxel—skin cancer	0.00164	0.00382	CcSEcCtD
Cyclizine—Hypersensitivity—Dactinomycin—skin cancer	0.00164	0.00382	CcSEcCtD
Cyclizine—Urticaria—Temozolomide—skin cancer	0.0016	0.00373	CcSEcCtD
Cyclizine—Asthenia—Dactinomycin—skin cancer	0.00159	0.00372	CcSEcCtD
Cyclizine—Pain—Fluorouracil—skin cancer	0.00158	0.0037	CcSEcCtD
Cyclizine—Muscle spasms—Docetaxel—skin cancer	0.00157	0.00368	CcSEcCtD
Cyclizine—Hypersensitivity—Temozolomide—skin cancer	0.00148	0.00346	CcSEcCtD
Cyclizine—Urticaria—Fluorouracil—skin cancer	0.00147	0.00343	CcSEcCtD
Cyclizine—Asthenia—Temozolomide—skin cancer	0.00144	0.00337	CcSEcCtD
Cyclizine—Pruritus—Temozolomide—skin cancer	0.00142	0.00332	CcSEcCtD
Cyclizine—Convulsion—Docetaxel—skin cancer	0.00142	0.00331	CcSEcCtD
Cyclizine—Hypertension—Docetaxel—skin cancer	0.00141	0.0033	CcSEcCtD
Cyclizine—Hypersensitivity—Fluorouracil—skin cancer	0.00136	0.00319	CcSEcCtD
Cyclizine—Anaphylactic shock—Docetaxel—skin cancer	0.00134	0.00312	CcSEcCtD
Cyclizine—Dizziness—Temozolomide—skin cancer	0.00133	0.0031	CcSEcCtD
Cyclizine—Nervous system disorder—Docetaxel—skin cancer	0.00131	0.00306	CcSEcCtD
Cyclizine—Pruritus—Fluorouracil—skin cancer	0.00131	0.00306	CcSEcCtD
Cyclizine—Tachycardia—Docetaxel—skin cancer	0.0013	0.00305	CcSEcCtD
Cyclizine—Skin disorder—Docetaxel—skin cancer	0.0013	0.00303	CcSEcCtD
Cyclizine—Headache—Temozolomide—skin cancer	0.00126	0.00294	CcSEcCtD
Cyclizine—Hypotension—Docetaxel—skin cancer	0.00125	0.00292	CcSEcCtD
Cyclizine—Dizziness—Fluorouracil—skin cancer	0.00122	0.00286	CcSEcCtD
Cyclizine—Insomnia—Docetaxel—skin cancer	0.00121	0.00282	CcSEcCtD
Cyclizine—Paraesthesia—Docetaxel—skin cancer	0.0012	0.0028	CcSEcCtD
Cyclizine—Somnolence—Docetaxel—skin cancer	0.00119	0.00277	CcSEcCtD
Cyclizine—Headache—Fluorouracil—skin cancer	0.00116	0.00271	CcSEcCtD
Cyclizine—Pain—Docetaxel—skin cancer	0.00114	0.00267	CcSEcCtD
Cyclizine—Constipation—Docetaxel—skin cancer	0.00114	0.00267	CcSEcCtD
Cyclizine—Hypersensitivity—Docetaxel—skin cancer	0.000984	0.0023	CcSEcCtD
Cyclizine—Asthenia—Docetaxel—skin cancer	0.000958	0.00224	CcSEcCtD
Cyclizine—Pruritus—Docetaxel—skin cancer	0.000945	0.00221	CcSEcCtD
Cyclizine—Dizziness—Docetaxel—skin cancer	0.000883	0.00206	CcSEcCtD
Cyclizine—Headache—Docetaxel—skin cancer	0.000837	0.00195	CcSEcCtD
